1Yazici Y,,Shi N,John A.Utilization of biologic agents in rheumatoid arthritis in the United States:analysis of prescribing patterns in16,752newly diagnosed patients and patients new to biologic therapy[].Bull NYUHosp Jt Dis.2008
2Nurmohamed MT,Dijkmans BA.Are biologics more effective than classical disease-modifying antirheumatic drugs[].Arthritis Research and Therapy.2008
3Alonso-Ruiz A,Pijoan JI,Ansuategui E,et al.Tumor necrosis factor alpha drugs in rheumatoid arthritis:systematic review and metaanalysis of efficacy and safety[].BMC Musculoskeletal Disorders.2008
4Bongartz T,Sutton AJ,Sweeting MJ,et al.Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials[].Journal of the American Medical Association The.2006
5DONAHUE KE,GARTLEHNER G,JONAS DE,et al.Systematic review:comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis[].Annals of Internal Medicine.2008
6Alonso-Ruiz A,Pijoan JI,Ansuategui E,et al.Tumor necrosis factor alpha drugs in rheumatoid arthritis:systematic review and metaanalysis of efficacy and safety[].BMC Musculoskeletal Disorders.2008
7Goekoop-Ruiterman YP,de Vries-Bouwstra JK,Allaart CF,et al.Comparison of treatment strategies in early rheumatoid arthri-tis:a randomized trial[].Annals of Internal Medicine.2007
8James R O’Dell.The BeSt Way to Treat Early Rheumatoid Arthritis?[].Annals of Internal Medicine.2007
9Sfriso P,Salaffi F,Montecucco CM,et al.MonitorNet:the Italian multicentre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice[].Reumatizam.2009
10Fabiola Atzeni,Marco Antivalle,Francesca Bobbio Pallavicini,et al.Predicting response to anti-TNF treatment in rheumatoid arthritis pa-tients[].Autoimmu Rev.2009
